CF PharmTech repurchases 4,000 H-shares at HK$20.82 apiece, lifting treasury stock to 641,000 shares

Bulletin Express04-28 20:23

CF PharmTech, Inc. filed a Next Day Disclosure Return on 28 April 2026, confirming a minor share buyback executed the same day on the Hong Kong Stock Exchange.

• Transaction details: 4,000 ordinary H-shares were repurchased on-market at prices ranging from HK$20.70 to HK$21.04, resulting in a volume-weighted average of HK$20.82 per share. The total consideration paid was HK$0.08 million.

• Impact on share capital: Issued shares (excluding treasury shares) declined marginally to 301.58 million, a 0.0013% reduction from the previous day. Outstanding treasury shares rose to 641,000, while the overall issued share count remained unchanged at 302.22 million.

• Mandate utilisation: Since the current repurchase mandate was approved on 16 December 2025, the company has bought back 641,000 shares, representing 0.2121% of the issued share base on the mandate date. The authorised limit allows for up to 30.22 million shares to be repurchased.

• Regulatory compliance: The company confirmed that all repurchases complied with Hong Kong listing rules and that a 30-day moratorium on new share issues or treasury share disposals is in effect until 28 May 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1106138707?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-28 20:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1106138707","market":"hk","top_or_hot":-1,"title":"CF PharmTech repurchases 4,000 H-shares at HK$20.82 apiece, lifting treasury stock to 641,000 shares","media":"Bulletin Express","content":"<p>CF PharmTech, Inc. filed a Next Day Disclosure Return on 28 April 2026, confirming a minor share buyback executed the same day on the Hong Kong Stock Exchange.</p>\n<p>• Transaction details: 4,000 ordinary H-shares were repurchased on-market at prices ranging from HK$20.70 to HK$21.04, resulting in a volume-weighted average of HK$20.82 per share. The total consideration paid was HK$0.08 million.</p>\n<p>• Impact on share capital: Issued shares (excluding treasury shares) declined marginally to 301.58 million, a 0.0013% reduction from the previous day. Outstanding treasury shares rose to 641,000, while the overall issued share count remained unchanged at 302.22 million.</p>\n<p>• Mandate utilisation: Since the current repurchase mandate was approved on 16 December 2025, the company has bought back 641,000 shares, representing 0.2121% of the issued share base on the mandate date. The authorised limit allows for up to 30.22 million shares to be repurchased.</p>\n<p>• Regulatory compliance: The company confirmed that all repurchases complied with Hong Kong listing rules and that a 30-day moratorium on new share issues or treasury share disposals is in effect until 28 May 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CF PharmTech repurchases 4,000 H-shares at HK$20.82 apiece, lifting treasury stock to 641,000 shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCF PharmTech repurchases 4,000 H-shares at HK$20.82 apiece, lifting treasury stock to 641,000 shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-28 20:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CF PharmTech, Inc. filed a Next Day Disclosure Return on 28 April 2026, confirming a minor share buyback executed the same day on the Hong Kong Stock Exchange.</p>\n<p>• Transaction details: 4,000 ordinary H-shares were repurchased on-market at prices ranging from HK$20.70 to HK$21.04, resulting in a volume-weighted average of HK$20.82 per share. The total consideration paid was HK$0.08 million.</p>\n<p>• Impact on share capital: Issued shares (excluding treasury shares) declined marginally to 301.58 million, a 0.0013% reduction from the previous day. Outstanding treasury shares rose to 641,000, while the overall issued share count remained unchanged at 302.22 million.</p>\n<p>• Mandate utilisation: Since the current repurchase mandate was approved on 16 December 2025, the company has bought back 641,000 shares, representing 0.2121% of the issued share base on the mandate date. The authorised limit allows for up to 30.22 million shares to be repurchased.</p>\n<p>• Regulatory compliance: The company confirmed that all repurchases complied with Hong Kong listing rules and that a 30-day moratorium on new share issues or treasury share disposals is in effect until 28 May 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02652","symbol_name":"长风药业","start_time":0,"source_url":"","article_id":"1106138707","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1106138707","pubTimestamp":1777379032,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"CF PharmTech, Inc. filed a Next Day Disclosure Return on 28 April 2026, confirming a minor share buyback executed the same day on the Hong Kong Stock Exchange. • Transaction details: 4,000 ordinary...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02652":"长风药业"},"translate_title":"CF PharmTech以每股20.82港元回购4,000股H股，库存股增至641,000股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02652":1},"content_text":"CF PharmTech, Inc. filed a Next Day Disclosure Return on 28 April 2026, confirming a minor share buyback executed the same day on the Hong Kong Stock Exchange.\n• Transaction details: 4,000 ordinary H-shares were repurchased on-market at prices ranging from HK$20.70 to HK$21.04, resulting in a volume-weighted average of HK$20.82 per share. The total consideration paid was HK$0.08 million.\n• Impact on share capital: Issued shares (excluding treasury shares) declined marginally to 301.58 million, a 0.0013% reduction from the previous day. Outstanding treasury shares rose to 641,000, while the overall issued share count remained unchanged at 302.22 million.\n• Mandate utilisation: Since the current repurchase mandate was approved on 16 December 2025, the company has bought back 641,000 shares, representing 0.2121% of the issued share base on the mandate date. The authorised limit allows for up to 30.22 million shares to be repurchased.\n• Regulatory compliance: The company confirmed that all repurchases complied with Hong Kong listing rules and that a 30-day moratorium on new share issues or treasury share disposals is in effect until 28 May 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1106138707","isCrawlerRequest":true}